PDL1 expression on neutrophils in patients ranged from 5.04 to 31.24% in breast cancer and 11.77–49.65% in melanoma (Table S5) suggesting that these immunoregulatory PDL1+ neutrophils may have an immunosuppressive role. Here, CD274 is linked to breast carcinoma.